40% off Cervical Cancer Screening

Cervical cancer is the third most common cancer in women worldwide, with over 600,000 new cases annually. In most cases, it is caused by persistent infection with high-risk HPV types.

Screening for cervical cancer is now offered with -40% discount.
 

🧪 What’s included? ↓

The HPV DNA test includes types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 because they are most frequently associated with the development of cervical cancer, responsible for over 90% of cases.

The PAP-test in liquid medium allows the identification of early cellular changes, even before symptoms appear. Together, these tests provide a complete screening, increasing the chance of early detection and prompt intervention.

Early detection through screening can reduce the risk of invasive cancer by up to 80%.

🗓️ Promotion period | 15 January – 15 February 2026
🩸 Available in any Invitro Diagnostics branch, without appointment.

Branch addresses